Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial
Main Authors: | Wechsler, M, Akuthota, P, Jayne, D, Khoury, P, Klion, A, Langford, C, Merkel, P, Moosig, F, Specks, U, Cid, M, Luqmani, R, Brown, J, Mallett, S, Philipson, R, Yancey, S, Steinfeld, J, Weller, P, Gleich, G |
---|---|
格式: | Conference item |
出版: |
American Thoracic Society
2017
|
相似书籍
-
Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
由: Wechsler, M, et al.
出版: (2017) -
OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial
由: Wechsler, M, et al.
出版: (2017) -
Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype
由: Benjamin Terrier, et al.
出版: (2023-07-01) -
Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
由: Ravi Ranjan Pradhan, et al.
出版: (2019-01-01) -
Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis
由: Giuseppe A. Ramirez, et al.
出版: (2022-12-01)